Seagen Inc. buy BiotechBee
Start price
07.09.22
/
60%
€152.08
Target price
31.12.24
€180.00
Performance (%)
21.00%
End price
21.03.23
€184.02
Summary
This prediction ended on 21.03.23 with a price of €184.02. The prediction had a final performance of 21.00%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Seagen Inc. | - | - | - | - |
| iShares Core DAX® | 1,43 % | 2,63 % | 12,46 % | 60,35 % |
| iShares Nasdaq 100 | 1,89 % | -0,46 % | 1,25 % | 85,81 % |
| iShares Nikkei 225® | -1,62 % | 11,10 % | 27,38 % | 64,40 % |
| iShares S&P 500 | 1,92 % | 1,16 % | 1,63 % | 59,42 % |
According to BiotechBee what are the pros and cons of Seagen Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Seagen Inc. diskutieren
Buy mit Kursziel 180,0